Publications
Detailed Information
Antibody Responses One Year after Mild SARS-CoV-2 Infection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choe, Pyoeng Gyun | - |
dc.contributor.author | Kim, Kye-Hyung | - |
dc.contributor.author | Kang, Chang Kyung | - |
dc.contributor.author | Suh, Hyeon Jeong | - |
dc.contributor.author | Kang, EunKyo | - |
dc.contributor.author | Lee, Sun Young | - |
dc.contributor.author | Kim, Nam Joong | - |
dc.contributor.author | Yi, Jongyoun | - |
dc.contributor.author | Park, Wan Beom | - |
dc.contributor.author | Oh, Myoung-don | - |
dc.date.accessioned | 2024-04-26T01:00:08Z | - |
dc.date.available | 2024-04-26T01:00:08Z | - |
dc.date.created | 2021-07-05 | - |
dc.date.issued | 2021-05 | - |
dc.identifier.citation | Journal of Korean Medical Science, Vol.36 No.21, pp.e157-4 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://hdl.handle.net/10371/199601 | - |
dc.description.abstract | Understanding the long-term kinetics of antibodies in coronavirus disease 2019 (COVID-19) is essential in interpreting serosurvey data. We investigated the antibody response one year after infection in 52 mildly symptomatic patients with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection, using three commercial immunoassays and a surrogate virus neutralization test (sVNT) kit. Anti-N pan-immunoglobulin (Ig), anti-S IgG, and anti-S1 IgG were detected in 43 (82.7%), 44 (84.6%), and 30 (57.7%), respectively. In 49 (94.2%), the antibody could be detected by either anti-N pan-Ig or anti-S IgG assay. In the sVNT, 30 (57.7%) had positive neutralizing activity. Despite waning immunity, SARS-CoV-2 antibodies can be detected up to one year after infection, even in mild COVID-19 patients. | - |
dc.language | 영어 | - |
dc.publisher | 대한의학회 | - |
dc.title | Antibody Responses One Year after Mild SARS-CoV-2 Infection | - |
dc.type | Article | - |
dc.identifier.doi | 10.3346/jkms.2021.36.e157 | - |
dc.citation.journaltitle | Journal of Korean Medical Science | - |
dc.identifier.wosid | 000657483000007 | - |
dc.identifier.scopusid | 2-s2.0-85107431958 | - |
dc.citation.endpage | 4 | - |
dc.citation.number | 21 | - |
dc.citation.startpage | e157 | - |
dc.citation.volume | 36 | - |
dc.identifier.kciid | ART002721905 | - |
dc.description.isOpenAccess | Y | - |
dc.contributor.affiliatedAuthor | Kim, Nam Joong | - |
dc.contributor.affiliatedAuthor | Park, Wan Beom | - |
dc.contributor.affiliatedAuthor | Oh, Myoung-don | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | SARS-CoV-2 | - |
dc.subject.keywordAuthor | Antibody | - |
dc.subject.keywordAuthor | ELISA | - |
dc.subject.keywordAuthor | ECLIA | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.